NCT02134171View on ClinicalTrials.gov

Early Predictive Factors of Cardiac and Cerebral Involvement in TMA

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

June 10, 2014

Primary Completion Date

July 4, 2017

Study Completion Date

July 30, 2017

Conditions
Thrombotic MicroangiopathiesThrombotic Thrombocytopenic Purpura
Interventions
OTHER

Biological and imaging investigations

From day 1 to day 3, specific blood tests will be performed (serum troponin Ic and brain natriuretic peptide \[BNP\]). A cardiac ultrasonography within the 4 first days and a cerebral MRI within the first 7 days after TMA diagnosis will be performed.

Trial Locations (1)

75012

Saint Antoine, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02134171 - Early Predictive Factors of Cardiac and Cerebral Involvement in TMA | Biotech Hunter | Biotech Hunter